TrialClinical and translational science2022

Upadacitinib pharmacokinetics and exposure-response analyses of efficacy and safety in psoriatic arthritis patients - Analyses of phase III clinical trials.

Elena Muensterman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.